FDA seeks med tech innovation to strengthen home care
By HME News Staff
Updated 10:07 AM CDT, Tue April 14, 2026
WASHINGTON – The U.S. Food and Drug Administration (FDA) has launched the Reducing Readmissions through Device Innovation for the Home (READI-Home) Innovation Challenge to accelerate patient access to medical device technologies aimed at reducing hospital readmission. As part of the FDA’s Center for Devices and Radiological Health’s (CDRH) Home as a Health Care Hub Initiative, the FDA invites innovators to pursue potential participation in the challenge by submitting proposed solutions for medical device technologies to be used in the home setting. These technologies would support patients and caregivers after an acute hospital stay and may help prevent avoidable readmissions. The challenge includes multiple phases:
- A submission period from April 7 – Sept. 30
- A selection period from Oct. 1 – Dec. 4
- An interaction period begins Dec. 5
The FDA anticipates selecting up to 9 devices from distinct manufacturers to move on to the interaction phase. It will consider:
- Description of the device and the clinical challenge it is intended to address
- Novelty of the device/concept
- Current development status of the device
- Data development plan (DDP) for the device
- Overview of key expertise within the team
- Anticipated impact
For more information, including how to submit a device, go here.
Comments